ADVERSE CLINICAL AND HEMODYNAMIC-EFFECTS OF ORAL LEVODOPA IN CHRONIC CONGESTIVE HEART-FAILURE

被引:16
作者
SHAH, PK
AMIN, DK
HORN, E
机构
[1] CEDARS SINAI MED CTR,DEPT MED,LOS ANGELES,CA 90048
[2] UNIV CALIF LOS ANGELES,SCH MED,LOS ANGELES,CA 90024
关键词
D O I
10.1016/0002-8703(85)90176-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:488 / 490
页数:3
相关论文
共 4 条
[1]   DOSE-RELATED HEMODYNAMIC AND RENAL EFFECTS OF DOPAMINE IN CONGESTIVE HEART-FAILURE [J].
BEREGOVICH, J ;
BIANCHI, C ;
RUBLER, S ;
LOMNITZ, E ;
CAGIN, N ;
LEVITT, B .
AMERICAN HEART JOURNAL, 1974, 87 (05) :550-557
[2]   BENEFICIAL HEMODYNAMIC-EFFECTS OF ORAL LEVODOPA IN HEART-FAILURE - RELATION TO THE GENERATION OF DOPAMINE [J].
RAJFER, SI ;
ANTON, AH ;
ROSSEN, JD ;
GOLDBERG, LI .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (21) :1357-1362
[3]  
RAJFER SI, 1982, EUR HEART J, V3, P103
[4]   COMBINED NITROPRUSIDE-DOPAMINE THERAPY IN SEVERE CHRONIC CONGESTIVE HEART-FAILURE - DOSE-RELATED HEMODYNAMIC ADVANTAGES OVER SINGLE DRUG INFUSIONS [J].
STEMPLE, DR ;
KLEIMAN, JH ;
HARRISON, DC .
AMERICAN JOURNAL OF CARDIOLOGY, 1978, 42 (02) :267-275